Literature DB >> 18975972

Identification of human intracellular targets of the medicinal Herb St. John's Wort by chemical-genetic profiling in yeast.

Patrick P McCue1, James M Phang.   

Abstract

St. John's wort (SJW; Hypericum perforatum L.) is commonly known for its antidepressant properties and was traditionally used to promote wound healing, but its molecular mechanism of action is not known. Here, chemical-genetic profiling in yeast was used to predict the human intracellular targets of an aqueous extract of SJW. SJW source material was authenticated by TLC, digital microscopy, and HPLC and further characterized by colorimetric methods for antioxidant activity, protein content, and total soluble phenolic content. SJW extract contained 1.76 microg/mL hyperforin, 10.14 microg/mL hypericin, and 46.05 microg/mL pseudohypericin. The effect of SJW extract on approximately 5900 barcoded heterozygous diploid deletion strains of Saccharomyces cerevisiae was investigated using high-density oligonucleotide microarrays. Seventy-eight yeast genes were identified as sensitive to SJW and were primarily associated with vesicle-mediated transport and signal transduction pathways. Potential human intracellular targets were identified using sequence-based comparisons and included proteins associated with neurological disease and angiogenesis-related pathways. Selected human targets were confirmed by cell-based immunocytochemical assays. The comprehensive and systematic nature of chemical-genetic profiling in yeast makes this technique attractive for elucidating the potential molecular mechanisms of action of botanical medicines and other bioactive dietary plants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975972      PMCID: PMC2645918          DOI: 10.1021/jf801593a

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  23 in total

1.  Determination of St. John's wort components in dietary supplements and functional foods by liquid chromatography.

Authors:  Catharina Y W Ang; Yanyan Cui; Hebron C Chang; Wenhong Luo; Thomas M Heinze; Lawrence J Lin; Antonia Mattia
Journal:  J AOAC Int       Date:  2002 Nov-Dec       Impact factor: 1.913

Review 2.  Pharmacokinetic interactions between herbal remedies and medicinal drugs.

Authors:  C Ioannides
Journal:  Xenobiotica       Date:  2002-06       Impact factor: 1.908

3.  Chemogenomic profiling: identifying the functional interactions of small molecules in yeast.

Authors:  Guri Giaever; Patrick Flaherty; Jochen Kumm; Michael Proctor; Corey Nislow; Daniel F Jaramillo; Angela M Chu; Michael I Jordan; Adam P Arkin; Ronald W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

4.  Antimicrobial and cytotoxic activity of rottlerin-type compounds from Hypericum drummondii.

Authors:  H Jayasuriya; J D McChesney; S M Swanson; J M Pezzuto
Journal:  J Nat Prod       Date:  1989 Mar-Apr       Impact factor: 4.050

5.  Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.

Authors:  Christoph M Schempp; Vladimir Kirkin; Birgit Simon-Haarhaus; Astrid Kersten; Judit Kiss; Christian C Termeer; Bernhard Gilb; Thomas Kaufmann; Christoph Borner; Jonathan P Sleeman; Jan C Simon
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

6.  Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy.

Authors:  D D Shoemaker; D A Lashkari; D Morris; M Mittmann; R W Davis
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

7.  A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity.

Authors:  G W Birrell; G Giaever; A M Chu; R W Davis; J M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.

Authors:  Heike Goehler; Maciej Lalowski; Ulrich Stelzl; Stephanie Waelter; Martin Stroedicke; Uwe Worm; Anja Droege; Katrin S Lindenberg; Maria Knoblich; Christian Haenig; Martin Herbst; Jaana Suopanki; Eberhard Scherzinger; Claudia Abraham; Bianca Bauer; Renate Hasenbank; Anja Fritzsche; Andreas H Ludewig; Konrad Büssow; Konrad Buessow; Sarah H Coleman; Claire-Anne Gutekunst; Bernhard G Landwehrmeyer; Hans Lehrach; Erich E Wanker
Journal:  Mol Cell       Date:  2004-09-24       Impact factor: 17.970

9.  HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer's disease.

Authors:  Jordi Clarimón; Jaume Bertranpetit; Mercè Boada; Lluís Tàrraga; David Comas
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-09       Impact factor: 2.680

10.  Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease.

Authors:  Yih-Ru Wu; Cheng-Kuang Wang; Chiung-Mei Chen; Yuying Hsu; Sih-Jing Lin; Yi-Ying Lin; Hon-Chung Fung; Kuo-Hsuan Chang; Guey-Jen Lee-Chen
Journal:  Hum Genet       Date:  2003-11-06       Impact factor: 4.132

View more
  5 in total

1.  Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.

Authors:  Birgit Kraus; Horst Wolff; Erich F Elstner; Jörg Heilmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

2.  A yeast-based genomic strategy highlights the cell protein networks altered by FTase inhibitor peptidomimetics.

Authors:  Giampiero Porcu; Cathal Wilson; Daniele Di Giandomenico; Antonella Ragnini-Wilson
Journal:  Mol Cancer       Date:  2010-07-23       Impact factor: 27.401

3.  Functional expression of parasite drug targets and their human orthologs in yeast.

Authors:  Elizabeth Bilsland; Pınar Pir; Alex Gutteridge; Alexander Johns; Ross D King; Stephen G Oliver
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

Review 4.  DNA Microarray-Based Screening and  Characterization of Traditional Chinese Medicine.

Authors:  Ryoiti Kiyama
Journal:  Microarrays (Basel)       Date:  2017-01-30

5.  Targeting the pregnane X receptor using microbial metabolite mimicry.

Authors:  Zdeněk Dvořák; Felix Kopp; Hao Li; Aneta Vrzalová; Cait M Costello; Jazmin S Kemp; Martina Štěpánková; Iveta Bartoňková; Eva Jiskrová; Karolína Poulíková; Barbora Vyhlídalová; Lars U Nordstroem; Chamini V Karunaratne; Harmit S Ranhotra; Kyu Shik Mun; Anjaparavanda P Naren; Iain A Murray; Gary H Perdew; Julius Brtko; Lucia Toporova; Arne Schön; Bret D Wallace; William G Walton; Matthew R Redinbo; Katherine Sun; Amanda Beck; Sandhya Kortagere; Michelle C Neary; Aneesh Chandran; Saraswathi Vishveshwara; Maria M Cavalluzzi; Giovanni Lentini; Julia Yue Cui; Haiwei Gu; John C March; Shirshendu Chatterjee; Adam Matson; Dennis Wright; Kyle L Flannigan; Simon A Hirota; Ryan Balfour Sartor; Sridhar Mani
Journal:  EMBO Mol Med       Date:  2020-03-10       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.